Direct Segment Aperture and Weight Optimization for Intensity-Modulated Radiotherapy of Prostate Cancer

Strahlentherapie und Onkologie

Volumn 180, Issue 3, 2004, Pages 136-143

  De Meerleer, Gert ^a   Vakaet, Luc ^a   De Gersem, Werner ^a   Villeirs, Geert ^a   De Neve, Wilfried ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

IMRT; Leaf optimization; Planning; Prostate cancer

Indexed keywords

ANISOTROPY; ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; DOSIMETRY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MALE; ORGAN WEIGHT; PARTIAL BODY RADIATION; PROBABILITY; PROSTATE CANCER; RADIATION DOSE; RADIATION MONITORING; RADIATION RESPONSE; SEGMENT OUTLINE AND WEIGHT ADAPTING TOOL; SEMINAL VESICLE; TREATMENT OUTCOME; TREATMENT PLANNING;

COLON, SIGMOID; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MODELS, THEORETICAL; PROBABILITY; PROSTATIC NEOPLASMS; RADIATION DOSAGE; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; RECTUM; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; URINARY BLADDER;

EID: 1542289777     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-004-1209-2     Document Type: Article

References (33)

1. Boersma LJ, van den Brink M, Bruce AM, et al. Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 Gy) conformal radiotherapy for prostate cancer, using dose-volume histograms. Int J Radiat Oncol Biol Phys 1998;41:83-92.
2. Burman C, Kutcher G, Emami B, et al. Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys 1991;21:123-35.
3. Claus F, De Gersem W, Vanhoutte I, et al. Evaluation of a leaf position tool for intensity modulated radiation therapy of head and neck cancer. Radiother Oncol 2001;61:281-6.
4. Claus F, Mijnheer B, Rash C, et al. Report of a study on IMRT planning strategies for ethmoid sinus cancer. Strahlenther Onkol 2002;178:572-6.
5. Coen JJ, Zietman AL, Thakral H, Shipley WU. Radical radiation for localized prostate cancer: local persistence of disease results in a late wave of metastases. J Clin Oncol 2002;20:3199-205.
6. De Gersem W, Claus F, De Wagter C, et al. An anatomy-based beam segmentation tool for intensity-modulated radiation therapy and its application to head-and-neck cancer. Int J Radiat Oncol Biol Phys 2001;51:849-59.
7. De Gersem W, Claus F, De Wagter C, et al. Leaf position optimisation for step-and-shoot IMRT. Int J Radiat Oncol Biol Phys 2001;51:1371-88.
8. De Meerleer GO, Vakaet LAML, De Gersem WRT, et al. Radiotherapy of prostate cancer with or without intensity modulated beams: a planning comparison. Int J Radiat Oncol Biol Phys 2000;47:639-48.
9. De Neve W, De Gersem W, De Meerleer G, et al. In response to Drs. Vaarkamp and Krasin. Int J Radiat Oncol Biol Phys 2001;49:1519-20.
10. Geinitz H, Zimmermann F, Wedel E von, et al. Biochemical control after conformal, 3-dimensional radiotherapy of prostatic carcinoma. Strahlenther Onkol 2002;178:369-77.
11. Goitein M, Niemierko A. Intensity modulated therapy and inhomogeneous dose to the tumour: A note of caution. Int J Radiat Oncol Biol Phys 1996;36:519-22.
12. Hanks GE, Hanlon AL, Schultheiss TE, et al. Dose escalation with 3D conformal treatment: five-year outcomes, treatment optimisation, and future directions. Int J Radiat Oncol Biol Phys 1998;41:501-10.
13. Hartford AC, Niemierko A, Adams JA, et al. Conformal irradiation of the prostate: estimating long-term rectal bleeding risk using dose-volume histograms. Int J Radiat Oncol Biol Phys 1996;36:721-30.
14. Kuban D, El-Mahdi AM, Schelhammer PF. Effect of local tumour control on distant metastasis and survival in prostatic adenocarcinoma. Urology 1987;30:420-6.
15. Kupelian PA, Reddy CA, Klein EA, et al. Short-course intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: preliminary results on late toxicity and quality of life. Int J Radiat Oncol Biol Phys 2001;51:988-93.
16. Kutcher GJ, Burman C. Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method. Int J Radiat Oncol Biol Phys 1989;16:1623-30.
17. Lee WL, Hanks GE, Hanlon AL, et al. Lateral rectal shielding reduces late rectal morbidity following high dose three-dimensional conformal radiation therapy for clinically localized prostate cancer: further evidence for a significant dose effect. Int J Radiat Oncol Biol Phys 1996;35:251-7.
18. Lyman JT. Complication probabilities as assessed from dose-volume histograms. Radiat Res Suppl 1985;8:S13-9.
19. Michalski JM, Purdy JA, Winter K, et al. Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406. Int J Radiat Oncol Biol Phys 2000;46:391-402.
20. Pirzkali A, Carol MP, Pickett B, et al. The effect of beam energy and number of fields on photon-based IMRT for deep-seated targets. Int J Radiat Oncol Biol Phys 2002;53:434-42.
21. Pollack A, Zagars GK, Smith LG, et al. Preliminary results of a randomised radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer. J Clin Oncol 2000;18:3904-11.
22. Pollack A, Zagars GK, Starkschall G, et al. Prostate cancer radiation dose response: results of the M.D. Anderson phase III randomised trial. Int J Radiat Oncol Biol Phys 2002;53:1097-105.
23. Sharma R, Duclos M, Chuba PJ, et al. Enhancement of prostate tumour volume definition with intravesical contrast: a three-dimensional dosimetric evaluation. Int J Radiat Oncol Biol Phys 1997;38:575-82.
24. Sherouse GW, Thorn J, Novins K. A portable 3D radiotherapy treatment design system. Med Phys 1989;16:466.
25. Skwarchuk MW, Jackson A, Zelefsky MJ, et al. Late rectal toxicity after conformal radiotherapy of prostate cancer (I): multivariate analysis and dose-response. Int J Radiat Oncol Biol Phys 2000;47:103-13.
26. Storey MR, Pollack A, Zagars G, et al. Complications from radiotherapy dose escalation in prostate cancer: preliminary results of a randomised trial. Int J Radiat Oncol Biol Phys 2000;48:635-42.
27. Teh BS, Mai W-Y, Uhl BM, et al. Intensity-modulated radiation therapy (IMRT) for prostate cancer with the use of a rectal balloon for prostate immobilization: acute toxicity and dose-volume analysis. Int J Radiat Oncol Biol Phys 2001;49:705-12.
28. Vaarkamp J, Krasin M. Reduction of target dose inhomogeneity in IMRT treatment planning using biologic objective functions. Int J Radiat Oncol Biol Phys 2001;49:1518-9.
29. Wachter S, Gerstner N, Goldner G, et al. Rectal sequelae after conformal radiotherapy of prostate cancer: dose-volume histograms as predicitve factors. Radiother Oncol 2001;59:65-70.
30. Wachter-Gerstner N, Wachter S, Goldner G, et al. Biochemical response after 3-D conformal radiotherapy of localized prostate cancer to a total dose of 66 Gy. Strahlenther Onkol 2002;178:542-7.
31. Webb S. Issues in delivering IMBs via the DMLC technique. In: Orton CG, Spaan JAE, Webster JG, eds. Intensity-modulated radiation therapy. Bristol: Institute of Physics, 2001:96-170.
32. Webb S, Nahum AE. A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density. Phys Med Biol 1993;38:653-66.
33. Zelefsky MJ, Fuks Z, Wolfe T, et al. Locally advanced prostatic cancer: long term toxicity outcome after three-dimensional conformal radiation therapy - a dose-escalation study. Radiology 1998;209:169-74.